Janusz Ławiński

838 total citations · 1 hit paper
15 papers, 494 citations indexed

About

Janusz Ławiński is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Janusz Ławiński has authored 15 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Janusz Ławiński's work include Renal cell carcinoma treatment (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Lipoproteins and Cardiovascular Health (2 papers). Janusz Ławiński is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Lipoproteins and Cardiovascular Health (2 papers). Janusz Ławiński collaborates with scholars based in Poland and United States. Janusz Ławiński's co-authors include Jacek Rysz, Beata Franczyk, Anna Gluba-Brzózka, Aleksandra Ciałkowska-Rysz, Robert Olszewski, Magdalena Rysz-Górzyńska, Zbigniew Jabłonowski and Henryk Zieliński and has published in prestigious journals such as International Journal of Molecular Sciences, Antioxidants and Toxins.

In The Last Decade

Janusz Ławiński

14 papers receiving 486 citations

Hit Papers

The Impact of CKD on Urem... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janusz Ławiński Poland 12 193 107 101 63 62 15 494
Tuncay Dağel Türkiye 10 139 0.7× 109 1.0× 181 1.8× 45 0.7× 92 1.5× 22 514
Yueqiang Wen China 15 129 0.7× 71 0.7× 206 2.0× 41 0.7× 109 1.8× 82 642
Nobuhiko Satoh Japan 15 242 1.3× 82 0.8× 81 0.8× 54 0.9× 86 1.4× 32 577
Dongling Luo China 12 109 0.6× 57 0.5× 58 0.6× 50 0.8× 56 0.9× 33 496
Raúl Fernández-Prado Spain 12 161 0.8× 113 1.1× 237 2.3× 42 0.7× 77 1.2× 19 535
Yanfang Luo China 8 113 0.6× 60 0.6× 68 0.7× 65 1.0× 43 0.7× 31 311
Zhimin Du China 14 133 0.7× 58 0.5× 84 0.8× 42 0.7× 97 1.6× 34 560
Katarzyna Taranta‐Janusz Poland 14 132 0.7× 183 1.7× 241 2.4× 91 1.4× 87 1.4× 53 756
Hye Yun Jeong South Korea 12 141 0.7× 57 0.5× 104 1.0× 30 0.5× 82 1.3× 29 420
Steven Ing United States 12 86 0.4× 77 0.7× 77 0.8× 47 0.7× 117 1.9× 40 502

Countries citing papers authored by Janusz Ławiński

Since Specialization
Citations

This map shows the geographic impact of Janusz Ławiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janusz Ławiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janusz Ławiński more than expected).

Fields of papers citing papers by Janusz Ławiński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janusz Ławiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janusz Ławiński. The network helps show where Janusz Ławiński may publish in the future.

Co-authorship network of co-authors of Janusz Ławiński

This figure shows the co-authorship network connecting the top 25 collaborators of Janusz Ławiński. A scholar is included among the top collaborators of Janusz Ławiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janusz Ławiński. Janusz Ławiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rysz, Jacek, Janusz Ławiński, Beata Franczyk, & Anna Gluba-Brzózka. (2025). Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma (ccRCC). International Journal of Molecular Sciences. 26(12). 5577–5577. 5 indexed citations
2.
Ławiński, Janusz, et al.. (2024). Efficacy and safety of photoselective vaporization of the prostate using the Greenlight XPS 180W laser and simple prostatectomy for high-volume prostate hypertrophy: A comparative analysis. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 77(1). 64–76.
3.
Franczyk, Beata, Jacek Rysz, Janusz Ławiński, Aleksandra Ciałkowska-Rysz, & Anna Gluba-Brzózka. (2023). Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma. Biomedicines. 11(1). 181–181. 11 indexed citations
4.
Gluba-Brzózka, Anna, Beata Franczyk, Magdalena Rysz-Górzyńska, Janusz Ławiński, & Jacek Rysz. (2023). The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease. Biomedicines. 11(9). 2358–2358. 18 indexed citations
5.
Franczyk, Beata, Anna Gluba-Brzózka, Aleksandra Ciałkowska-Rysz, Janusz Ławiński, & Jacek Rysz. (2023). The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review. International Journal of Molecular Sciences. 24(5). 4653–4653. 60 indexed citations
6.
Gluba-Brzózka, Anna, Jacek Rysz, Janusz Ławiński, & Beata Franczyk. (2022). Renal Cell Cancer and Obesity. International Journal of Molecular Sciences. 23(6). 3404–3404. 22 indexed citations
7.
Rysz, Jacek, et al.. (2022). The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma. International Journal of Molecular Sciences. 24(1). 643–643. 15 indexed citations
8.
Franczyk, Beata, Anna Gluba-Brzózka, Janusz Ławiński, Magdalena Rysz-Górzyńska, & Jacek Rysz. (2021). Metabolomic Profile in Venous Thromboembolism (VTE). Metabolites. 11(8). 495–495. 23 indexed citations
9.
Rysz, Jacek, Beata Franczyk, Janusz Ławiński, et al.. (2021). The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins. 13(4). 252–252. 195 indexed citations breakdown →
10.
Franczyk, Beata, Jacek Rysz, Janusz Ławiński, Magdalena Rysz-Górzyńska, & Anna Gluba-Brzózka. (2021). Is a High HDL-Cholesterol Level Always Beneficial?. Biomedicines. 9(9). 1083–1083. 49 indexed citations
11.
Gluba-Brzózka, Anna, Beata Franczyk, Magdalena Rysz-Górzyńska, Janusz Ławiński, & Jacek Rysz. (2021). Emerging Anti-Atherosclerotic Therapies. International Journal of Molecular Sciences. 22(22). 12109–12109. 16 indexed citations
12.
Rysz, Jacek, Beata Franczyk, Janusz Ławiński, & Anna Gluba-Brzózka. (2021). Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC). International Journal of Molecular Sciences. 23(1). 151–151. 21 indexed citations
13.
Rysz, Jacek, Beata Franczyk, Janusz Ławiński, & Anna Gluba-Brzózka. (2020). Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases. Antioxidants. 9(11). 1079–1079. 39 indexed citations
14.
Rysz, Jacek, Beata Franczyk, Janusz Ławiński, Robert Olszewski, & Anna Gluba-Brzózka. (2020). The Role of Metabolic Factors in Renal Cancers. International Journal of Molecular Sciences. 21(19). 7246–7246. 18 indexed citations
15.
Ławiński, Janusz & Zbigniew Jabłonowski. (2018). [The analysis of perioperative complications of percutaneous nephrolithotomy in the treatment of nephrolithiasis with the use of modified Clavien-Dindo classification].. PubMed. 44(260). 49–53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026